MER Primary Care Conferences Internal Medicine for Primary Care Geri Neuro Rheum Sep 25-27, 2026

100 $

+ Include:  videos + file sub vtt, size:  GB

+ Target Audience: Internists, Family Medicine Physicians, Neurologists, Rheumatologists, Geriatricians, and Cardiologists

Description

+ Include:  videos + file sub vtt, size:  GB

+ Target Audience: Internists, Family Medicine Physicians, Neurologists, Rheumatologists, Geriatricians, and Cardiologists

+ Sample video: contact me for sample video

+ Information:

Internal Medicine for Primary Care: Geriatrics/Neurology/Rheumatology is an exceptional continuing medical education program organized by Medical Education Resources (MER). Held at the Wynn Las Vegas, this conference is designed to provide primary care clinicians with comprehensive, evidence-based updates and pragmatic management strategies across the key disciplines of neurology, rheumatology, and geriatrics. Through concise, practice-oriented lectures, case studies, and interactive discussions, attendees will gain actionable clinical insights into differentiating neurological symptoms, diagnosing and treating complex inflammatory and crystal arthropathies, and managing high-mortality cardiovascular and geriatric conditions such as heart failure and hypertension in older adults.

Learning Objectives

Upon completion of this program, participants should be better able to:

  • Utilize history and physical examination to distinguish weakness from non-specific symptoms.

  • Discuss evidence-based management options for Alzheimer’s disease.

  • Describe the differential diagnosis and treatment options for migraine headaches.

  • Utilize prevention and treatment strategies for cerebrovascular disorders.

  • Compare and contrast inflammatory & non-inflammatory joint pain and their differential diagnoses.

  • Review the risks and benefits of the treatment options for arthritis (non-selective NSAIDs, COX-2 inhibitors, DMARDs, narcotics, and tramadol).

  • Diagnose and treat gout and pseudogout.

  • Compare the benefits and side effect profiles of pharmacologic treatment options for fibromyalgia.

  • Describe the assessment and evidence-based treatment plans for heart failure (both reduced and preserved ejection fraction) in collaboration with cardiology.

  • Utilize discussion and case-based learning to further incorporate treatment options for heart failure into practice.

  • Evaluate hypertension in both younger and older adults, differentiate risks and goals of treatment, and recommend appropriate interventions.

  • Utilize discussion and case-based learning to further incorporate treatment options for hypertension into practice.

Target Audience

This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.

Best for Internists, Family Medicine Physicians, Neurologists, Rheumatologists, Geriatricians, and Cardiologists.

Topics

  • Friday, September 25, 2026

    • Neurology: Evaluating Weakness (Using history and physical examination to distinguish weakness from non-specific symptoms; characteristics of neurological diseases that produce weakness; presentations of representative diseases of the nervous system)

    • Neurology: Alzheimer’s & Other Dementias (Definition; statistics; neurological changes of normal aging; pathology; etiological theories; vascular dementias; investigations; social issues; symptomatic treatment; research therapies)

    • Neurology: Headaches & Migraines (Basic headache mechanisms; headache history: characteristics, precipitating factors, medical conditions; migraine: common tension, classic, treatment, complicated, cluster, sinus; trigeminal neuralgia; Giant Cell Arteritis; brain tumor; subarachnoid hemorrhage; emergency room treatment)

    • Rheumatology: Evaluating the Patient with Joint Pain (Differentiating between inflammatory and non-inflammatory joint pain; the utility of joint aspiration and lab work-up with interpretation of synovial fluid analysis; differential diagnosis of joint pain and inflammatory arthritis)

    • Rheumatology: Update in Pharmacology for Arthritis (Review risks and benefits of traditional NSAIDs and COX-2 inhibitors; analgesics [narcotics and tramadol], acetaminophen, conventional-synthetic DMARDs, and bDMARDs)

  • Saturday, September 26, 2026

    • Rheumatology: Crystal Disease: Gout & Pseudogout (Properly diagnosing and treating crystal diseases such as gout and pseudogout)

    • Rheumatology: Fibromyalgia (Differential diagnosis and treatment of this difficult-to-manage pain syndrome; treatment options of anti-epileptics and SNRIs)

    • Neurology: Cerebrovascular Disorders (Epidemiology; identifying the high-risk patient; treatment effects; transient neurological deficit: carotid, vertebrobasilar; non-specific cerebral symptoms; migraines vs. TIA; treatment options)

    • Geriatrics: Heart Failure in Older Adults (Recognition of the high mortality associated with heart failure; understanding how to diagnose heart failure and the difference between reduced ejection fraction and preserved ejection fraction heart failure; evidence-based treatments available for heart failure)

    • Geriatrics: Heart Failure Discussion and Q&A (Interactive review of the principles of heart failure diagnosis and treatment in older adults, and audience questions further clarifying the topic)

  • Sunday, September 27, 2026

    • Geriatrics: Controversies in the Management of Hypertension in Older Adults (Best evidence for treatment goals for hypertension in diabetics and those with previous stroke; controversial evidence for the various guidelines for diagnosing and treating hypertension in older adults; best evidence-based medications for hypertension)

    • Geriatrics: Hypertension Discussion and Q&A (Interactive review of the principles of hypertension diagnosis and treatment in older adults, and audience questions further clarifying the topic)

Reviews

There are no reviews yet.

Be the first to review “MER Primary Care Conferences Internal Medicine for Primary Care Geri Neuro Rheum Sep 25-27, 2026”

Your email address will not be published. Required fields are marked *

sixty one − fifty four =
Powered by MathCaptcha